Sangrix vs Sentage
SGRX and SNTG side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SGRX and SNTG compare
Sentage scores higher on the StockData Score (6 against 5 for Sangrix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SGRX | SNTG |
|---|---|---|
| Size and price | ||
| Share price | $2.56 | $1.72 |
| Change, 1 year | −99.6% | −14.4% |
| Change, 5 years | −100.0% | −80.4% |
| Beta (5Y) | 1.40 | 1.15 |
| Employees | 1 | 1 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | – | −35.9% |
| Revenue growth, 5Y average | – | −54.7% |
| Profitability | ||
| Gross margin | – | 91.2% |
| Operating margin | – | −3301% |
| Net margin | – | −3305% |
| Return on equity | – | −25.2% |
| Return on invested capital | −286% | −22.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 6.98 (better) | 2.14 |
| Piotroski F-score | – | 3 |
| Ownership | ||
| Held by insiders | – | 62.2% |
| Short interest, % of float | – | 0.73% |
Go deeper
- SGRX stock overview
- SGRX income statement
- SGRX valuation and score
- SNTG stock overview
- SNTG income statement
- SNTG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.